Jack Jallo, MD, PhD

Jack Jallo, MD, PhD

Contact Dr. Jallo

909 Walnut Street
Suite 200
Philadelphia, Pennsylvania 19107

(215) 955-7000
(215) 503-9170 fax

Most Recent Peer-reviewed Publications

  1. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial
  2. Duration of posttraumatic amnesia predicts neuropsychological and global outcome in complicated mild traumatic brain injury
  3. ICES (Intraoperative Stereotactic Computed Tomography-Guided Endoscopic Surgery) for brain hemorrhage: A multicenter randomized controlled trial
  4. Acute Traumatic Coagulopathy Accompanying Isolated Traumatic Brain Injury is Associated with Worse Long-Term Functional and Cognitive Outcomes
  5. Traumatic intraconal foreign body: Report of an injury corrected with combined surgical and endoscopic treatment
  6. Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury
  7. A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
  8. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT)
  9. A multicenter, single-blind, prospective randomized trial to evaluate the safety of a polyethylene glycol hydrogel (duraseal dural sealant system) as a dural sealant in cranial surgery
  10. Nociceptive neuropeptide increases and periorbital allodynia in a model of traumatic brain injury
  11. An analysis of phenytoin vs. levetiracetam for early seizure pharmacoprophylaxis following TBI
  12. Comments
  13. Analysis of nonmodifiable risk factors for intracranial aneurysm rupture in a large, retrospective cohort.
  14. Comments
  15. Editorial comment
  16. Editorial comment
  17. Analysis of non-modifiable risk factors for intracranial aneurysm rupture in a large, retrospective cohort
  18. Comments
  19. Editorial comment
  20. Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury